Stock Markets February 16, 2026

NatWest Shares Jump After UBS Lifts Earnings Forecasts and Reaffirms Buy Call

UBS raises multi-year EPS estimates, points to stronger-than-expected Q4 performance and improved capital metrics

By Nina Shah NWG
NatWest Shares Jump After UBS Lifts Earnings Forecasts and Reaffirms Buy Call
NWG

NatWest Group PLC shares climbed 4.6% after UBS increased its earnings forecasts for 2026-28 and kept a 'buy' rating with a 780p target. UBS flagged stronger-than-expected fourth-quarter results, better net interest income and lower-than-anticipated impairments, while NatWest's CET1 ratio reached 14.0% including a £750 million buyback tied to the Evelyn Partners deal.

Key Points

  • NatWest shares rose 4.6% after UBS raised EPS forecasts and kept a 'buy' rating with a 780p price target.
  • UBS increased diluted EPS estimates by 5% for 2026, 4% for 2027 and 3% for 2028, citing stronger-than-expected Q4 performance including NII and lower impairments.
  • NatWest's CET1 ratio reached 14.0% (30 bps above consensus) and includes a £750 million buyback tied to the Evelyn Partners transaction; 2028 targets imply modest upside to market expectations.

NatWest Group PLC shares advanced 4.6% on Monday following an updated earnings outlook from UBS that lifted diluted earnings-per-share projections for multiple years and retained a positive stance on the stock.

Analyst action and market reaction

UBS maintained its "buy" rating and a price target of 780p on NatWest, a level the bank says implies roughly a 40% total return from current levels. Alongside that rating, UBS raised its diluted EPS forecasts by 5% for 2026, 4% for 2027 and 3% for 2028, a revision that preceded the share-price uplift.

Fourth-quarter performance

In its review, UBS said NatWest's fourth-quarter pre-tax profit, excluding notable items and litigation charges, came in about 7% ahead of consensus. Net interest income (NII) beat expectations by 3%, operating expenses were largely in line with forecasts, and impairment charges were markedly lighter than anticipated, performing 30% better than expected at 13 basis points of loans.

UBS highlighted the bank's operational momentum, pointing to loan and deposit growth and a notable improvement in net interest margin. The bank reported an 8 basis point improvement in NIM versus the market's expected 2 basis points increase.

Capital position and buyback

NatWest's common equity tier 1 (CET1) ratio reached 14.0%, which UBS noted was 30 basis points above consensus forecasts. That CET1 figure incorporates a £750 million buyback the bank announced in conjunction with the Evelyn Partners transaction.

Guidance and targets

UBS said NatWest's guidance for 2026 is broadly in line with market consensus. The bank's newly disclosed 2028 targets, according to UBS, imply roughly 2-3% upside versus current market expectations and are viewed as achievable. Those targets include:

  • Return on tangible equity above 18%
  • Customer assets and liabilities growing at more than 4% compound annual growth
  • Cost-to-income ratio below 45%
  • Operating with an approximate 13.0% CET1 ratio

Outlook

UBS's combination of upward EPS revisions, positive commentary on near-term performance metrics and a continued buy rating underpinned the market response. The brokerage's analysis places emphasis on stronger capital generation and improved margin dynamics as drivers behind the revised outlook.


Note: This report presents the details of UBS's updated forecasts and NatWest's reported metrics as communicated in the reviewed statements.

Risks

  • Execution risk in meeting the 2028 targets: UBS describes the 2028 targets as achievable, but these remain forward-looking targets dependent on continued momentum.
  • Capital deployment and CET1 impact: the reported CET1 ratio includes a £750 million buyback, indicating that capital-return decisions and transaction-related actions could affect regulatory capital metrics.
  • Margin and asset quality sensitivity: UBS's upgrade reflects an 8 basis point NIM improvement and lower impairments; any reversal in margin trends or deterioration in loan impairments could alter the outlook.

More from Stock Markets

Indigenous Occupation Halts Operations at Cargill’s Santarem Terminal Feb 21, 2026 Market Turbulence Reinforces Case for Broader Diversification Feb 21, 2026 NYSE Holdings UK Ltd launches unified trading platform to streamline market access Feb 21, 2026 Earnings Drive Weekly Winners and Losers as Buyout Headlines Lift Masimo Feb 21, 2026 Barclays Sees 'Physical AI' Scaling to Hundreds of Billions by 2035 Feb 21, 2026